Circulating, resting memory B cells have also been detected in convalescent individuals [36]; a memory B‐cell response to SARS‐CoV‐2 evolves during the first 6 months after infection, characterized with greater somatic hypermutation, resistance to mutations in the RBD of the spike protein, and increased potency [37]. Here, CHMP5 is linked to infection.